Atlas Trials

AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)

Clinical trial NCT02677350 · WITHDRAWN

Trial details

NCT number
NCT02677350
Sponsor
Joshua M Hare
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Crohn's DiseaseFistulizing Crohn's DiseaseStem Cells
Start date
2019-12-01
Primary completion
2025-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.